What is the downside for Procter&Gamble's stock?
According to analysts' consensus price target of $157.50, Procter & Gamble has a forecasted downside of 3.1% from its current price of $162.60. Procter & Gamble has only been the subject of 3 research reports in the past 90 days.
What are Wall Street analysts'price targets for Procter&Gamble's stock?
12 Wall Street analysts have issued 12-month price targets for Procter & Gamble's stock. Their forecasts range from $138.00 to $179.00. On average, they expect Procter & Gamble's share price to reach $157.50 in the next twelve months.
Where can I buy Procter&Gamble stock?
Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Procter & Gamble's stock price today? One share of PG stock can currently be purchased for approximately $162.60.
How much does Procter&Gamble stock pay a dividend?
Procter & Gamble pays an annual dividend of $3.48 per share and currently has a dividend yield of 2.18%. Procter & Gamble has been increasing its dividend for 65 consecutive years, indicating the company has a strong committment to maintain and grow its dividend.
Is Procter & Gamble stock a Buy, Sell or Hold?
Procter & Gamble stock has received a consensus rating of buy. The average rating score is Aa3 and is based on 24 buy ratings, 8 hold ratings, and...
What was the 52-week low for Procter & Gamble stock?
The low in the last 52 weeks of Procter & Gamble stock was 131.96. According to the current price, Procter & Gamble is 107.57% away from the 52-wee...
What was the 52-week high for Procter & Gamble stock?
The high in the last 52 weeks of Procter & Gamble stock was 165.31. According to the current price, Procter & Gamble is 85.87% away from the 52-wee...
What are analysts forecasts for Procter & Gamble stock?
The 32 analysts offering price forecasts for Procter & Gamble have a median target of 160.06, with a high estimate of 180.00 and a low estimate of...
Procore Announces Fourth Quarter and Full Year 2021 Financial Results
CARPINTERIA, Calif., February 22, 2022--Procore Technologies, Inc. (NYSE: PCOR), a leading global provider of construction management software, today announced financial results for the fourth quarter and full year ended December 31, 2021.
Is a Surprise Coming for Procore Technologies (PCOR) This Earnings Season?
Procore Technologies (PCOR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Is Procore Technologies, Inc. (NYSE:PCOR) Popular Amongst Insiders?
Every investor in Procore Technologies, Inc. ( NYSE:PCOR ) should be aware of the most powerful shareholder groups...
Olay Body Unveils New Fearless Artist Series to Elevate Stories of Women of Color in Art and Science
CINCINNATI, February 24, 2022--Olay Body is launching the Fearless Artist Series, a new collection of body washes that feature bottle artwork designed by African American artist, Avery Williamson, and formulas specially crafted by a diverse team of women.
4 Dividend Stocks That Should Pay You Forever
Dividends are a source of passive income to supplement the earnings from your job, while also helping defray higher expenses from rising inflation. There are a wide variety of dividend companies, but investors need to look for those with a consistent history of rising payouts.
About Procaps Group S.A
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.
Headlines
Could The Procaps Group, S.A. (NASDAQ:PROC) Ownership Structure Tell Us Something Useful?
1.3 Analyst's Opinion
Procter & Gamble has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 6 buy ratings, 6 hold ratings, and no sell ratings.
Is Procter & Gamble a buy right now?
12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Procter & Gamble in the last year. There are currently 6 hold ratings and 6 buy ratings for the stock.
How has Procter & Gamble's stock been impacted by COVID-19 (Coronavirus)?
Procter & Gamble's stock was trading at $111.59 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, PG stock has increased by 43.3% and is now trading at $159.90. View which stocks have been most impacted by COVID-19.
When is Procter & Gamble's next earnings date?
Procter & Gamble is scheduled to release its next quarterly earnings announcement on Tuesday, April 19th 2022. View our earnings forecast for Procter & Gamble.
How were Procter & Gamble's earnings last quarter?
The Procter & Gamble Company (NYSE:PG) announced its earnings results on Wednesday, January, 19th. The company reported $1.66 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.65 by $0.01. The business earned $20.95 billion during the quarter, compared to analyst estimates of $20.34 billion.
How often does Procter & Gamble pay dividends? What is the dividend yield for Procter & Gamble?
Procter & Gamble declared a quarterly dividend on Tuesday, January 11th. Investors of record on Friday, January 21st will be paid a dividend of $0.8698 per share on Tuesday, February 15th. This represents a $3.48 annualized dividend and a yield of 2.18%.
Is Procter & Gamble a good dividend stock?
Procter & Gamble pays an annual dividend of $3.48 per share and currently has a dividend yield of 2.18%. Procter & Gamble has been increasing its dividend for 65 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Procter & Gamble is 61.48%.
